Lexicon Pharmaceuticals LXRX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $67.09M+5.9% | $63.33M-19.5% | $78.66M+56.2% | $50.36M-19.9% | $62.89M-5.7% | ||
| $132.57M+114% | $61.9M-6.6% | $66.29M-43.6% | $117.64M-10.8% | $131.95M-23.0% | ||
| $29M0.0% | $29M0.0% | $29M0.0% | $29M— | —— | ||
| $11.78M+394% | $2.38M+2.1% | $2.33M+6.9% | $2.18M-95.4% | $47.45M+1,266% | ||
| $276K-1.8% | $281K+77.8% | $158K-6.0% | $168K-16.4% | $201K-13.0% | ||
| $3.32M+10.6% | $3M-26.6% | $4.09M+9.6% | $3.73M+12.3% | $3.32M-26.8% | ||
| $186.03M+82.6% | $101.9M-16.8% | $122.53M-15.5% | $145.08M-41.0% | $245.81M-0.2% | ||
| $1.75M-5.9% | $1.86M-6.0% | $1.98M-7.1% | $2.13M-7.6% | $2.31M-7.1% | ||
| $2.82M+4.1% | $2.71M+4.6% | $2.59M+6.2% | $2.44M+7.8% | $2.26M+8.4% | ||
| 10.5%0.0% | 10.5%-0.1% | 10.6%+0.9% | 9.7%0.0% | 9.7%-483,199,990% | ||
| $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | ||
| $368K0.0% | $368K0.0% | $368K0.0% | $368K0.0% | $368K0.0% | ||
| $268.82M+45.3% | $184.99M-10.2% | $205.93M-8.7% | $225.58M-24.2% | $297.67M-0.3% | ||
| $3M-2.8% | $3.08M-18.8% | $3.8M-35.6% | $5.9M-44.8% | $10.69M-27.8% | ||
| $6.9M-47.7% | $13.19M-3.2% | $13.62M+18.6% | $11.48M-11.3% | $12.95M-57.5% | ||
| $0-100% | $4.6M— | —— | —— | $42.06M— | ||
| $1.64M0.0% | $1.64M0.0% | $1.64M+80.6% | $909K-12.9% | $1.04M-11.1% | ||
| $9.9M-52.6% | $20.87M-3.9% | $21.72M-37.7% | $34.84M-68.5% | $110.69M+145% | ||
| $49.68M+0.6% | $49.41M-12.6% | $56.51M+0.7% | $56.11M-4.3% | $58.64M-41.5% | ||
| $6.38M-3.3% | $6.6M-2.9% | $6.8M+53.2% | $4.44M-1.9% | $4.52M-1.7% | ||
| $8.02M-2.6% | $8.23M-2.4% | $8.44M+57.9% | $5.34M-4.0% | $5.56M-3.7% | ||
| $6.38M-11.1% | $7.17M-4.9% | $7.54M+45.0% | $5.2M-1.9% | $5.3M-23.4% | ||
| $65.96M-14.8% | $77.45M-9.7% | $85.77M-10.8% | $96.14M-44.9% | $174.64M+14.5% | ||
| $4K— | $0— | $0— | $0— | $0— | ||
| 450M0.0% | 450M0.0% | 450M0.0% | 450M0.0% | 450M+123,867% | ||
| $2.22B+4.4% | $2.13B+0.1% | $2.13B+0.2% | $2.12B+0.2% | $2.12B+0.1% | ||
| -$2.02B-0.1% | -$2.02B-0.8% | -$2B-0.6% | -$1.99B+0.2% | -$1.99B-1.3% | ||
| -$130K-533% | $30K+3.4% | $29K+307% | -$14K-156% | $25K-79.0% | ||
| $2.84M-45.2% | $5.19M0.0% | $5.19M0.0% | $5.19M0.0% | $5.19M+12.4% | ||
| $202.86M+88.6% | $107.54M-10.5% | $120.16M-7.2% | $129.44M+5.2% | $123.03M-15.7% | ||
| $268.82M+45.3% | $184.99M-10.2% | $205.93M-8.7% | $225.58M-24.2% | $297.67M-0.3% | ||
| $123.1M+4,824% | $2.5M-84.7% | $16.3M-78.7% | $76.4M+33.3% | $57.3M+344% | ||
| $123.1M+4,824% | $2.5M-84.7% | $16.3M-78.7% | $76.4M+33.3% | $57.3M+344% | ||
| $123.1M+4,824% | $2.5M-84.7% | $16.3M-78.7% | $76.4M+33.3% | $57.3M+344% | ||
| $132.57M+114% | $61.9M-6.6% | $66.29M-43.6% | $117.64M-10.8% | $131.95M-23.0% | ||
| $3.32M+10.6% | $3M-26.6% | $4.09M+9.6% | $3.73M+12.3% | $3.32M-26.8% | ||
| $368K0.0% | $368K0.0% | $368K0.0% | $368K0.0% | $368K0.0% | ||
| $7.12M-2.7% | $7.32M-2.5% | $7.51M+68.5% | $4.46M-4.1% | $4.65M-3.8% | ||
| $7.12M-2.7% | $7.32M-2.5% | $7.51M+68.5% | $4.46M-4.1% | $4.65M-3.8% | ||
| $368K0.0% | $368K0.0% | $368K0.0% | $368K0.0% | $368K0.0% | ||
| $4.57M0.0% | $4.57M0.0% | $4.57M0.0% | $4.57M0.0% | $4.57M0.0% | ||
| $132.57M+114% | $61.9M-6.6% | $66.29M-43.6% | $117.64M-10.8% | $131.95M-23.0% | ||
| $7.12M-2.7% | $7.32M-2.5% | $7.51M+68.5% | $4.46M-4.1% | $4.65M-3.8% | ||
| $368K0.0% | $368K0.0% | $368K0.0% | $368K0.0% | $368K0.0% | ||
| $2.75M-57.2% | $6.42M+34.0% | $4.79M+11.5% | $4.29M+13.7% | $3.78M-74.3% | ||
| $6.9M-47.7% | $13.19M-3.2% | $13.62M+18.6% | $11.48M-11.3% | $12.95M-57.5% | ||
| $6.9M-47.7% | $13.19M-3.2% | $13.62M+18.6% | $11.48M-11.3% | $12.95M-57.5% | ||
| $2.75M-57.2% | $6.42M+34.0% | $4.79M+11.5% | $4.29M+13.7% | $3.78M-74.3% | ||
| $1.68M— | —— | $1.65M+90.6% | $865K0.0% | $865K— | ||
| $1.75M— | —— | $1.72M+91.3% | $898K0.0% | $898K— | ||
| $1.68M— | —— | $1.65M+90.6% | $865K0.0% | $865K— | ||
| $1.72M— | —— | $1.68M+91.0% | $881K0.0% | $881K— | ||
| $1.75M— | —— | $1.72M+91.3% | $898K0.0% | $898K— | ||
| $1.22M— | —— | $424K-18.1% | $518K-40.5% | $871K— | ||
| $11.22M— | —— | $12.07M+52.6% | $7.91M-4.3% | $8.26M— | ||
| $3.2M— | —— | $3.63M+41.7% | $2.56M-4.9% | $2.7M— | ||
| $1.72M— | —— | $1.68M+91.0% | $881K0.0% | $881K— | ||
| $1.86M— | —— | $1.75M+91.8% | $914K0.0% | $914K— | ||
| $1.75M— | —— | $1.72M+91.3% | $898K0.0% | $898K— | ||
| $1.86M— | —— | $1.75M+91.8% | $914K0.0% | $914K— | ||
| $2.98M— | —— | $4.84M+26.4% | $3.83M0.0% | $3.83M— | ||
| $2.98M— | —— | $4.84M+26.4% | $3.83M0.0% | $3.83M— | ||
| $6.9M-47.7% | $13.19M-3.2% | $13.62M+18.6% | $11.48M-11.3% | $12.95M-57.5% | ||
| $57.71M-7.3% | $62.24M-4.2% | $64.95M+5.7% | $61.45M-42.2% | $106.26M+0.2% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 425.7M+16.4% | 365.8M0.0% | 365.8M0.0% | 365.8M+0.1% | 365.6M+0.7% | ||
| 5B0.0% | 5B0.0% | 5B0.0% | 5B0.0% | 5B0.0% | ||
| 2.7M+17.7% | 2.3M0.0% | 2.3M0.0% | 2.3M0.0% | 2.3M0.0% | ||
| 408.4K— | 0— | 0— | 0— | 0— | ||
| $426K+16.4% | $366K0.0% | $366K0.0% | $366K0.0% | $366K+0.8% | ||
| $4K— | $0— | $0— | $0— | $0— | ||
| $2.84M-45.2% | $5.19M0.0% | $5.19M0.0% | $5.19M0.0% | $5.19M+12.4% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $4.57M0.0% | $4.57M0.0% | $4.57M0.0% | $4.57M0.0% | $4.57M0.0% | ||
| $618K-78.9% | $2.93M-44.9% | $5.32M+25.0% | $4.26M-31.7% | $6.23M-49.1% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $450M0.0% | $450M0.0% | $450M0.0% | $450M0.0% | $450M0.0% | ||
| $425.71M+16.4% | $365.85M0.0% | $365.78M0.0% | $365.78M+0.1% | $365.56M+0.7% | ||
| $425.71M+16.4% | $365.85M0.0% | $365.78M— | —— | —— | ||
| $123.1M+4,824% | $2.5M-84.7% | $16.3M-78.7% | $76.4M+33.3% | $57.3M+344% | ||
| $11.22M— | —— | $12.07M+52.6% | $7.91M-4.3% | $8.26M— | ||
| $3.2M— | —— | $3.63M+41.7% | $2.56M-4.9% | $2.7M— | ||
| $0.110.0% | $0.11-0.9% | $0.11+9.3% | $0.10.0% | $0.1-8.5% | ||
| $1.9M-13.8% | $2.2M+17.7% | $1.87M-7.6% | $2.02M+6.6% | $1.9M-17.8% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $5B0.0% | $5B0.0% | $5B0.0% | $5B0.0% | $5B0.0% | ||
| $2.71M+17.7% | $2.3M0.0% | $2.3M0.0% | $2.3M0.0% | $2.3M0.0% | ||
| $408.44K— | $0— | $0— | $0— | $0— | ||
| $29M0.0% | $29M0.0% | $29M0.0% | $29M— | —— | ||
| $1.93M-18.8% | $2.38M0.0% | $2.38M0.0% | $2.38M0.0% | $2.38M+55.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Lexicon Pharmaceuticals's total assets?
- Lexicon Pharmaceuticals (LXRX) holds $268.8M in total assets, down 9.7% year over year.
- How much debt does Lexicon Pharmaceuticals have?
- Lexicon Pharmaceuticals carries $57.7M in total debt against $202.9M of shareholders' equity, a debt-to-equity ratio of 0.28.
- How much cash does Lexicon Pharmaceuticals have?
- Lexicon Pharmaceuticals holds $67.1M in cash and equivalents.
- Can Lexicon Pharmaceuticals cover its short-term obligations?
- Its current ratio is 18.79 — current assets exceed current liabilities.
- Where does Lexicon Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
